CAS 692737-80-7

4-Amino-5-fluoro-3-(6-(4-methylpiperazin-1-yl)-1H-benzo[d]imidazol-2-yl)quinolin-2(1H)-one 2-hydroxypropanoate

CAS : 692737-80-7

Formule : C₂₄H₂₇FN₆O₄

Degré de pureté : 95%

Couleur et forme : Solid

Masse moléculaire : 482.5074

Ref: IN-DA006NEX

Dovitinib lactate

CAS : 692737-80-7

Dovitinib lactate

Degré de pureté : ≥98%

Masse moléculaire : 482.51g/mol

Ref: 54-BUP15512

Dovitinib Lactate Salt

CAS : 692737-80-7

Dovitinib Lactate Salt

Formule : C₂₁H₂₁FN₆O·C₃H₆O₃

Degré de pureté : 99.98% (Typical Value in Batch COA)

Couleur et forme : yellow-brown solid

Masse moléculaire : 482.51g/mol

Ref: 54-BIFK0016

Dovitinib lactate

CAS : 692737-80-7

Dovitinib lactate (TKI-258 lactate)(TKI258) lactate is a potent inhibitor of fibroblast growth factor receptor 3 (FGFR3) (IC50 :5 nM).

Formule : C₂₄H₂₇FN₆O₄

Degré de pureté : 99.54% - 99.77%

Couleur et forme : Solid

Masse moléculaire : 482.51

Ref: TM-T7104

Dovitinib Lactate

Produit contrôlé

CAS : 692737-80-7

Applications Dovitinib is used in treating melanoma.
References Renhowe, P., et al.: J. Med. Chem., 52, 278 (2009),

Formule : C₂₁H₂₁FN₆O·C₃H₆O₃

Couleur et forme : Neat

Masse moléculaire : 392.43 + 90.08

Ref: TR-D537000

Dovitinib Lactate Salt

CAS : 692737-80-7

Dovitinib is a tyrosine kinase inhibitor that is used for the treatment of non-small cell lung cancer, renal cell carcinoma and other cancers. Dovitinib inhibits tumor growth by blocking the cell factor (c-KIT) and the stem cell factor receptor (c-MET). It also inhibits tumor angiogenesis through its inhibition of the colony-stimulating factor 1 receptor (CSF1R), which is involved in regulating hematopoietic stem cells. Dovitinib has been shown to inhibit tumor growth by blocking antiapoptotic genes, such as Bcl2, BclxL, Bfl-1 and Mcl-1. This drug has a terminal half-life of 15 hours.

Formule : C₂₄H₂₇FN₆O₄

Degré de pureté : Min. 95%

Masse moléculaire : 482.51 g/mol

Ref: 3D-SCB73780